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Abstract
Previous studies of the biosynthetic enzymes involved in the assembly of scytonemin (1), a
cyanobacterial sunscreen, have identified β-ketoacid 2 as an important intermediate that is produced
by ThDP-dependent enzyme ScyA. We now report that ScyC, previously annotated as a hypothetical
protein, catalyzes cyclization and decarboxylation of 2 to generate ketone 5. Assembly of the
cyclopentyl[b]indole structure in this manner has little precedent in the chemical literature.
Additional mechanistic experiments have revealed that cyclization likely precedes decarboxylation
and that the latter event may provide a driving force for cyclopentane formation.
The dimeric alkaloid scytonemin (1) is synthesized by numerous strains of cyanobacteria.1 It
is one of the few bacterial secondary metabolites to have a confirmed role as a sunscreen;
expression of the scytonemin biosynthetic gene cluster is triggered by exposure to UV-A,
resulting in extracellular pigment accumulation and blockage of further incident radiation.1,2
In addition to this important function, scytonemin also possesses kinase inhibitory activity3
and an unusual chemical structure.4
We have recently proposed a possible biosynthetic route to scytonemin (Scheme 1a) and
performed in vitro characterization of two enzymes encoded in the biosynthetic gene cluster,
5 ScyA (NpR1276) and ScyB (NpR1275).6 ScyB, a leucine dehydrogenase homolog, converts
L-tryptophan to indole-3 pyruvic acid (3). ScyA is a thiamin (ThDP)-dependent enzyme
responsible for the regioselective acyloin coupling of 3 and p-hydroxyphenylpyruvic acid (4)
to afford a single, labile β-ketoacid product (2). Our previous work revealed the biosynthetic
logic involved in assembling the linear carbon backbone of the scytonemin skeleton.7 However,
many important questions concerning pigment assembly remained unaddressed, including the
enzyme(s) responsible for cyclopentane formation and the mechanism of this unusual
transformation. In this report we disclose the discovery that ScyC (NpR1274), an enzyme
encoded by the scytonemin cluster, catalyzes cyclization and decarboxylation of ScyA product
christopher_walsh@hms.harvard.edu.
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t2 to form ketone 5, thereby constructing the indole-fused cyclopentane moiety of the natural
product.
The cyclopentyl[b]indole ring system is found in several other secondary metabolites,
including the bruceollines8 and the indole-diterpene mycotoxins.9 To date no enzymes
involved in the assembly of this structure have been characterized in vitro. Consequently,
identifying the scytonemin biosynthetic enzymes responsible for cyclization was a significant
challenge.
Of the uncharacterized genes in the scytonemin cluster, scyC (NpR1274), encoding a
hypothetical protein, was deemed the best initial candidate as its lack of an N-terminal signal
peptide sequence might simplify overexpression and could indicate involvement early in the
scytonemin pathway, before pigment export from the cyanobacterial cells. ScyC was amplified
from N. punctiforme ATCC 29133 genomic DNA, subcloned into pET-28b and -29b vectors,
and overexpressed in E. coli as N- and C-His6-tagged fusions. Preliminary screens for
enzymatic activity were performed using unpurified cell-free extracts as cofactor requirements
were uncertain. Assays were performed in tandem with ThDP-dependent enzyme ScyA, with
ScyC extract added to the reaction mixture after conversion to β-ketoacid 2 from pyruvic acid
derivatives 3 and 4 was complete as judged by HPLC analysis. After the introduction of ScyC,
appearance of a new peak was accompanied by the disappearance of 2 (see Supporting
Information for all HPLC data). The qualitative rate of product formation was greatly reduced
with extracts from uninduced cultures. Additionally, extracts generated from E. coli strains
lacking a scyC construct did not exhibit any conversion.
Preliminary attempts to isolate and characterize the new product from large-scale enzymatic
reactions were complicated by its facile decomposition. Ultimately, a sodium borohydride
quench afforded two stable, separable products, diastereomeric cyclopentanols 6a and 6b, in
a 5.5:1 ratio (Scheme 1b).10 The formation of the cyclopentyl[b]indole skeleton was confirmed
by NMR analysis (1H, 13C, HSQC, HMBC) and the relative stereochemistry assigned from
1D-NOE experiments. These data clearly indicate that 6a and 6b derive from reduction of a
ketone precursor (5), the immediate product of the ScyC reaction. The ratio and configuration
of the diastereomeric alcohol products are consistent with hydride delivery from the less
sterically hindered face of 5. Additionally, quenching experiments with sodium borodeuteride
show deuterium incorporation only at the carbon atom bearing the alcohol (see Supporting
Information).
We next focused on further characterization of the ScyC enzyme and its mechanism. Activity
was retained after large-scale overexpression and purification of both ScyC fusions, indicating
minimal additional cofactor requirements; this considerably narrows the potential mechanisms
of the ScyC-mediated transformation.11 We initially considered the two possibilities outlined
in Figure 2a. In pathway A, initial intramolecular attack by the indole ring onto the ketone at
the C2 position could be followed by dehydration to generate an electophilic iminium
intermediate that would undergo facile decarboxylation. Tautomerization of the resulting enol
would afford ketone 5. Alternatively, an initial decarboxylation step might occur, providing
one of two possible α-hydroxyketones (7 or 8). Either intermediate could potentially be
processed to 5 via substitution or carbonyl addition mechanisms (Pathways B and C).
To distinguish between these possibilities, we evaluated the ability of ScyC to accept
decarboxylated intermediates. Treatment of a mixture of α-hydroxyketones regioisomers (7:
8 = 1.4:1)12 with ScyC in the presence of both ThDP and Mg2+ resulted in no product formation
(Scheme 2b). The possibility of ScyC inhibition by 7 or 8 was ruled out by doping tandem
ScyA/ScyC assay mixtures; no change in the qualitative rate of formation of ketone 5 was
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tobserved in the presence of 7 and 8 in comparison to a DMSO control. Based on these
experiments, we favor pathway A as a reasonable mechanism for the action of ScyC.
One of the most interesting aspects of the ScyC-catalyzed cyclization is the lack of analogous
reactions in the chemical literature. Synthetic and medicinal chemists have developed various
strategies to access the cyclopentyl[b]indole motif due to its potential biological activity.13
However, none of these methods have employed an intramolecular attack of an
unfunctionalized indole onto a pendant ketone; this is perhaps surprising given the widespread
use of intramolecular indole cyclizations to form β-carboline derivatives and may reflect the
difficulty of such transformations.14 In contrast, intermolecular additions of indoles to ketones
have been described.15 We hypothesize that intramolecular reactions may involve reversible
indole attack and that a thermodynamic driving force is needed for successful cyclopentane
formation. This proposal is supported by reports of cyclizations onto carboxylic acid
derivatives, which may be driven by the departure of the carbonyl substituent.9f,g ScyC may
overcome the problem of reversibility by coupling ring formation to decarboxylation. This
logic is akin to Nature’s use of malonyl thioesters in decarboxylative Claisen condensations
to drive iterative C–C bond formations in fatty acid and polyketide chain elongations.16
Overall, we have discovered that enzymes ScyA and ScyC act in tandem to construct the
tricyclic cyclopentyl[b]indole framework needed for scytonemin biosythesis. ScyA produces
a single β-ketoacid isomer (2), which undergos a facile, non-enzymatic decarboxylation.
However, in the presence of ScyC, this off-pathway reaction is suppressed in favor of an
intramolecular cyclization, and the resultant cyclopentyl intermediate is primed for
decarboxylation to trap out the annular cyclopentyl[b]indole as an irreversible event. At the
time of our initial experiments we could not readily explain the preferential formation of a
single isomer by ScyA; the discovery of the ScyC provides that missing insight, as only the
observed β-ketoacid regioisomer (2) could have a ketone appropriately positioned for
cyclization. The ScyC product 5 is only one oxidation state away from a potential dimerization
substrate (9) that could be progressed to the complete scytonemin skeleton.
We have commented above that direct cyclizations to form cyclopentyl[b]indole scaffolds have
been elusive, indicating that additional study of the structure and mechanism of ScyC is
warranted. Efforts toward further characterization of this enzyme, as well as investigation of
the remaining steps in scytonemin biosynthesis, are currently underway.
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